#312 on the rich list of 14,644 insiders
George Yancopoulos
Bd. Co-Chair, President & CSO at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
$855M
in disclosed stock, −$20.5M (−2.35%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 312th of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Dec 31, 2025
What the $855M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 310,460 | $923.34 | $287M | 33.5% | Form 4, Dec 31, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 2025 GRAT | 200,000 | $923.34 | $185M | 21.6% | Form 4, Dec 31, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Trust for Chldn. | 180,000 | $923.34 | $166M | 19.4% | Form 4, Dec 31, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 2024 GRAT II | 101,988 | $923.34 | $94.2M | 11.0% | Form 4, Dec 31, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 2024 GRAT | 71,487 | $923.34 | $66.0M | 7.7% | Form 4, Dec 31, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Children | 56,048 | $923.34 | $51.8M | 6.1% | Form 4, Dec 31, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 401(k) Plan | 5,962 | $923.34 | $5.5M | 0.6% | Form 4, Dec 31, 2025 |
Share counts are the amounts George Yancopoulos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 309 | Dwight A. Merriman Director, MongoDB. New York, NY | $865M |
| 310 | Albert H. Nahmad Chairman and CEO, Watsco. Miami, FL | $864M |
| 311 | Marc Zahr Co-President, Blue Owl Capital. New York, NY | $857M |
| 312 | George Yancopoulos Bd. Co-Chair, President & CSO, Regeneron Pharmaceuticals. Tarrytown, NY | $855M |
| 313 | Scott Kleinman Co-President (See Remarks), Apollo Global Management. New York, NY | $853M |
| 314 | Mallika Srinivasan 10% owner, AGCO | $848M |
| 315 | Jeremy Allaire Chairman and CEO, Circle Internet. New York, NY | $848M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- P. Roy Vagelos$431MDirector. #529 overall
- Neil E. Stahl$54.7MEVP Research and Development. #2374 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Joseph LaRosa$44.4MEVP General Counsel and Secret. #2766 overall
- Daniel P. Van Plew$32.5MEVP & General Mgr, Industrial. #3541 overall
Questions
How much stock does George Yancopoulos own?
George Yancopoulos holds $854,962,056 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 312th on the Stock Rich List.
Is this George Yancopoulos's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.